A labelled synthetic Tryptamine (T894600) hallucinogen which has been used psychotherapeutically in humans, but has been studied preclinically to a lesser extent. Studies suggest that it has agonist activity at 5-HT1A and 5-HT2A receptors and that effects at 5-HT2A receptors mask effects at 5-HT1A receptors.
Dangerous Goods Info:
Fantegrossi, W.E. et al.: Pharmacol. Biochem. Behav., 88, 358 (2008); Li, J. et al.: Behav. Pharmacol., 18, 283 (2007);